Triftazine tablets 5 mg, 50 pcs. (trifluoperazine)
Special Price
$17.85
Regular Price
$21.00
In stock
SKU
newyork527911
Latin name
Triphtazinum Buy Triftazine tablets 5 mg, 50 pcs. (trifluoperazine) in newyork free shipping. Fast international shipping USA, AU, EU, UK and others.
Triphtazinum Buy Triftazine tablets 5 mg, 50 pcs. (trifluoperazine) in newyork free shipping. Fast international shipping USA, AU, EU, UK and others.
Latin name
Triphtazinum
Packing
50 pcs
Indications
schizophrenia and other mental illnesses occurring with delusions, hallucinations and psychomotor agitation
vomiting of central origin.
Contraindications
increased individual sensitivity
inhibition of central nervous system (CNS) function and coma of any etiology of
brain injury
liver disease, kidney and blood-forming organs with impaired
function progressive systemic diseases of the brain and spinal cord and spinal cord 12 duodenal ulcer during exacerbation of
heart failure in the stage of decompensation severe arterial hypotension of the disease, accompanied by the risk of thromboembolic complications
angle-closure glaucoma (risk of increased intraocular pressure)
prostatic hyperplasia
myxedema
pregnancy, breastfeeding
children under 3 years of age.
Caution:
Old age, vomiting (the antiemetic effect of phenothiazines may mask vomiting associated with an overdose of other drugs).
Triftazine is used after comparing the risk and benefit of treatment in patients with alcohol intoxication, Reye's syndrome, cachexia, as well as breast cancer, Parkinson’s disease, gastric and duodenal ulcer, urinary retention, chronic respiratory diseases (especially in children), epileptic seizures.
Special instructions
During treatment, regular monitoring of blood pressure, pulse and liver, kidney and blood function is necessary.
Do not allow alcohol during treatment!
During the treatment period, it is necessary to refrain from engaging in potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.
Composition of
in 1 coated tablet, contains:
active substance: trifluoperazine hydrochloride 5 mg
excipients: refined sugar, potato starch, aerosil, calcium stearate, gelatin, basic magnesium carbonate, indigo carmine, polyvinylpyrrolidone, wax, titanium dioxide, talc.
Side effects
From the nervous system: drowsiness, dizziness, insomnia, phenomena of mental indifference (with prolonged use), delayed reactions to external irritations. The use of triftazine is often accompanied by extrapyramidal disorders (dyskinesias, akinetorigid phenomena, akathisia, hyperkinesis, tremors, autonomic disorders), in isolated cases, convulsions. Antiparkinsonian drugs such as tropacin, trihexyphenidyl (cyclodol) and others are used as correctors. Dyskinesias (paroxysmal cramps in the muscles of the neck, tongue, bottom of the mouth, oculogyric crises) are stopped with sodium caffeine benzoate (2 ml of a 20% solution subcutaneously) and atropine (1 ml of 0.1% solution subcutaneously).
With prolonged use, the development of tardive dyskinesia, less commonly, malignant antipsychotic syndrome, is possible.
From the senses: paresis of accommodation, with prolonged use - retinopathy, clouding of the lens and cornea.
From the genitourinary system: urinary retention, decreased potency, frigidity, decreased libido, ejaculation disorders, priapism, oliguria.
From the endocrine system: hypo- or hyperglycemia, glucosuria, amenorrhea, hyperprolactinemia, dysmenorrhea, galactorrhea, swelling or pain in the mammary glands, gynecomastia, weight gain.
From the digestive system: dry mouth, decreased appetite, constipation, bulimia, nausea, vomiting, diarrhea, gastralgia, cholestatic jaundice.
On the part of the sensory organs: visual impairment - paresis of accommodation (at the beginning of treatment), retinopathy, clouding of the lens and cornea.
Laboratory indicators: thrombocytopenia, lympho- and leukopenia, increased blood coagulation, anemia, agranulocytosis (more often at 4-10 weeks of treatment), pancytopenia, eosinophilia - less often than other phenothiazines, false-positive pregnancy tests.
From the cardiovascular system: tachycardia, decreased blood pressure (including orthostatic hypotension) especially in elderly patients and people suffering from alcoholism, heart rhythm disturbances, lengthening of the QT interval, decrease or inversion of the T wave. Allergic reactions: skin rash, urticaria, angioedema (less often than other phenothiazines).
Other: pigmentation of the skin and conjunctiva, discoloration of the sclera and cornea, decreased tolerance to high temperatures (up to the development of heat stroke), melanosis.
Local reactions: intramuscular administration may cause infiltrates, and if liquid forms get on the skin - contact dermatitis.
Drug interaction
With the simultaneous use of triftazine with other drugs, maprotilin or monoamine oxidase inhibitors (MAOs) - increased risk of developing antipsychotic malignant syndrome with anticonvulsants - possibly lowering the seizure threshold with drugs for treating hyperthyroidism - increasing the risk of agranulocytosis with other drugs causing extrapyramidal reactions - possibly increasing the frequency and severity of extrapyramidal disorders with hypritic srdlp - severe orthostatic hypotension with ephedrine is possible - vasoconstriction is weakened effect of ephedrine. In the treatment with triftazine, administration of epinephrine (adrenaline) should be avoided, as the effect of epinephrine can be distorted, which can lead to a drop in blood pressure. The antiparkinsonian effect of levodopa is reduced due to blocking of dopamine receptors. Triftazine can suppress the effects of amphetamines, clonidine, guanethidine. Triftazin enhances the anticholinergic effects of other drugs, while the antipsychotic effect of antipsychotics may decrease.
With the simultaneous use of triftazine with prochlorperazine, prolonged loss of consciousness may occur.
Combination with lithium preparations increases the risk of extrapyramidal complications. Triftazin may mask some manifestations of ototoxicity (tinnitus, dizziness), drugs that have an ototoxic effect (e.g. antibiotics). Other hepatotoxic drugs increase the risk of hepatotoxicity. Antacids containing Al3 + and Mg2 + reduce the absorption of triftazine.
Overdose
Symptoms: areflexia or hyperreflexia, fuzzy visual perception, cardiotoxicity (arrhythmia, heart failure, decrease in blood pressure, shock, tachycardia, change in QRS complex, fibrillation, fibrillation convulsions, disorientation, drowsiness, stupor or coma mydriasis, dry mouth, hyperpyrexia or hypothermia, muscle rigidity, vomiting, pulmonary edema or respiratory depression.
Treatment - symptomatic: with arrhythmia - intravenous (in / in) phenytoin 9-11 mg / kg, with heart failure - cardiac glycosides, with marked decrease in blood pressure - intravenous injection of fluid or vasopressor agents, such as norepinephrine, phenylephrine (avoid the appointment of alpha- and beta-adrenomimetics, such as epinephrine, because it is possible paradoxical decrease in blood pressure due to blockade of alpha-adrenoceptors by trifluoperazine), in convulsions - diazepam (avoid the appointment of barbiturates, due to possible respiratory failure). parkinsonism - diphenyltropine, diphenhydramine. Monitoring of cardiovascular function for at least 5 days, CNS function, breathing, body temperature measurement, psychiatrist consultation. Dialysis is ineffective.
Storage Conditions
In a dry, dark place, out of the reach of children.
Shelf life
3 years.
Active ingredient
Trifluoperazine
Dosage form
tablets
Possible Product Names
TRIFTAZINE TAB. PO 5MG No. 50
TRIFTAZINE TABL.P.O. 5MG N50
Triftazine tablets 5 mg 50 pcs.
Triftazine tablets 5 mg, 50 pcs.
Health, Russian
Triftazine tablets 5 mg, 50 pcs. (trifluoperazine) newyork in pharmacy online. Cheap price, instruction, side effects, dosage. Triftazine tablets 5 mg, 50 pcs. - Sale. PayPal accept. Free shipping newyork. Fast international shipping.
Triphtazinum
Packing
50 pcs
Indications
schizophrenia and other mental illnesses occurring with delusions, hallucinations and psychomotor agitation
vomiting of central origin.
Contraindications
increased individual sensitivity
inhibition of central nervous system (CNS) function and coma of any etiology of
brain injury
liver disease, kidney and blood-forming organs with impaired
function progressive systemic diseases of the brain and spinal cord and spinal cord 12 duodenal ulcer during exacerbation of
heart failure in the stage of decompensation severe arterial hypotension of the disease, accompanied by the risk of thromboembolic complications
angle-closure glaucoma (risk of increased intraocular pressure)
prostatic hyperplasia
myxedema
pregnancy, breastfeeding
children under 3 years of age.
Caution:
Old age, vomiting (the antiemetic effect of phenothiazines may mask vomiting associated with an overdose of other drugs).
Triftazine is used after comparing the risk and benefit of treatment in patients with alcohol intoxication, Reye's syndrome, cachexia, as well as breast cancer, Parkinson’s disease, gastric and duodenal ulcer, urinary retention, chronic respiratory diseases (especially in children), epileptic seizures.
Special instructions
During treatment, regular monitoring of blood pressure, pulse and liver, kidney and blood function is necessary.
Do not allow alcohol during treatment!
During the treatment period, it is necessary to refrain from engaging in potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.
Composition of
in 1 coated tablet, contains:
active substance: trifluoperazine hydrochloride 5 mg
excipients: refined sugar, potato starch, aerosil, calcium stearate, gelatin, basic magnesium carbonate, indigo carmine, polyvinylpyrrolidone, wax, titanium dioxide, talc.
Side effects
From the nervous system: drowsiness, dizziness, insomnia, phenomena of mental indifference (with prolonged use), delayed reactions to external irritations. The use of triftazine is often accompanied by extrapyramidal disorders (dyskinesias, akinetorigid phenomena, akathisia, hyperkinesis, tremors, autonomic disorders), in isolated cases, convulsions. Antiparkinsonian drugs such as tropacin, trihexyphenidyl (cyclodol) and others are used as correctors. Dyskinesias (paroxysmal cramps in the muscles of the neck, tongue, bottom of the mouth, oculogyric crises) are stopped with sodium caffeine benzoate (2 ml of a 20% solution subcutaneously) and atropine (1 ml of 0.1% solution subcutaneously).
With prolonged use, the development of tardive dyskinesia, less commonly, malignant antipsychotic syndrome, is possible.
From the senses: paresis of accommodation, with prolonged use - retinopathy, clouding of the lens and cornea.
From the genitourinary system: urinary retention, decreased potency, frigidity, decreased libido, ejaculation disorders, priapism, oliguria.
From the endocrine system: hypo- or hyperglycemia, glucosuria, amenorrhea, hyperprolactinemia, dysmenorrhea, galactorrhea, swelling or pain in the mammary glands, gynecomastia, weight gain.
From the digestive system: dry mouth, decreased appetite, constipation, bulimia, nausea, vomiting, diarrhea, gastralgia, cholestatic jaundice.
On the part of the sensory organs: visual impairment - paresis of accommodation (at the beginning of treatment), retinopathy, clouding of the lens and cornea.
Laboratory indicators: thrombocytopenia, lympho- and leukopenia, increased blood coagulation, anemia, agranulocytosis (more often at 4-10 weeks of treatment), pancytopenia, eosinophilia - less often than other phenothiazines, false-positive pregnancy tests.
From the cardiovascular system: tachycardia, decreased blood pressure (including orthostatic hypotension) especially in elderly patients and people suffering from alcoholism, heart rhythm disturbances, lengthening of the QT interval, decrease or inversion of the T wave. Allergic reactions: skin rash, urticaria, angioedema (less often than other phenothiazines).
Other: pigmentation of the skin and conjunctiva, discoloration of the sclera and cornea, decreased tolerance to high temperatures (up to the development of heat stroke), melanosis.
Local reactions: intramuscular administration may cause infiltrates, and if liquid forms get on the skin - contact dermatitis.
Drug interaction
With the simultaneous use of triftazine with other drugs, maprotilin or monoamine oxidase inhibitors (MAOs) - increased risk of developing antipsychotic malignant syndrome with anticonvulsants - possibly lowering the seizure threshold with drugs for treating hyperthyroidism - increasing the risk of agranulocytosis with other drugs causing extrapyramidal reactions - possibly increasing the frequency and severity of extrapyramidal disorders with hypritic srdlp - severe orthostatic hypotension with ephedrine is possible - vasoconstriction is weakened effect of ephedrine. In the treatment with triftazine, administration of epinephrine (adrenaline) should be avoided, as the effect of epinephrine can be distorted, which can lead to a drop in blood pressure. The antiparkinsonian effect of levodopa is reduced due to blocking of dopamine receptors. Triftazine can suppress the effects of amphetamines, clonidine, guanethidine. Triftazin enhances the anticholinergic effects of other drugs, while the antipsychotic effect of antipsychotics may decrease.
With the simultaneous use of triftazine with prochlorperazine, prolonged loss of consciousness may occur.
Combination with lithium preparations increases the risk of extrapyramidal complications. Triftazin may mask some manifestations of ototoxicity (tinnitus, dizziness), drugs that have an ototoxic effect (e.g. antibiotics). Other hepatotoxic drugs increase the risk of hepatotoxicity. Antacids containing Al3 + and Mg2 + reduce the absorption of triftazine.
Overdose
Symptoms: areflexia or hyperreflexia, fuzzy visual perception, cardiotoxicity (arrhythmia, heart failure, decrease in blood pressure, shock, tachycardia, change in QRS complex, fibrillation, fibrillation convulsions, disorientation, drowsiness, stupor or coma mydriasis, dry mouth, hyperpyrexia or hypothermia, muscle rigidity, vomiting, pulmonary edema or respiratory depression.
Treatment - symptomatic: with arrhythmia - intravenous (in / in) phenytoin 9-11 mg / kg, with heart failure - cardiac glycosides, with marked decrease in blood pressure - intravenous injection of fluid or vasopressor agents, such as norepinephrine, phenylephrine (avoid the appointment of alpha- and beta-adrenomimetics, such as epinephrine, because it is possible paradoxical decrease in blood pressure due to blockade of alpha-adrenoceptors by trifluoperazine), in convulsions - diazepam (avoid the appointment of barbiturates, due to possible respiratory failure). parkinsonism - diphenyltropine, diphenhydramine. Monitoring of cardiovascular function for at least 5 days, CNS function, breathing, body temperature measurement, psychiatrist consultation. Dialysis is ineffective.
Storage Conditions
In a dry, dark place, out of the reach of children.
Shelf life
3 years.
Active ingredient
Trifluoperazine
Dosage form
tablets
Possible Product Names
TRIFTAZINE TAB. PO 5MG No. 50
TRIFTAZINE TABL.P.O. 5MG N50
Triftazine tablets 5 mg 50 pcs.
Triftazine tablets 5 mg, 50 pcs.
Health, Russian
Triftazine tablets 5 mg, 50 pcs. (trifluoperazine) newyork in pharmacy online. Cheap price, instruction, side effects, dosage. Triftazine tablets 5 mg, 50 pcs. - Sale. PayPal accept. Free shipping newyork. Fast international shipping.
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review